| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 167 |
| 1 | INFLIXIMAB | 71 |
| 2 | METHOTREXATE SODIUM | 65 |
| 3 | METHOTREXATE | 54 |
| 4 | USTEKINUMAB | 51 |
| 5 | PREDNISONE | 48 |
| 6 | ACETAMINOPHEN | 32 |
| 7 | VEDOLIZUMAB | 32 |
| 8 | METRONIDAZOLE | 28 |
| 9 | OMEPRAZOLE MAGNESIUM | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MENTHOL AND BENZOCAINE | 1 | 0.0185 |
| 1 | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | 1 | 0.0081 |
| 2 | ANORECTAL OINTMENT | 1 | 0.0046 |
| 3 | AZATHIOPRINE SODIUM | 8 | 0.0032 |
| 4 | L-TRYPTOPHAN | 1 | 0.0023 |
| 5 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| 6 | BALSALAZIDE DISODIUM | 1 | 0.0019 |
| 7 | MENTHOL, METHYL SALICYLATE | 1 | 0.0017 |
| 8 | HYDROCORTISONE VALERATE | 1 | 0.0016 |
| 9 | BEVACIZUMAB-BVZR | 1 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 101 |
| 1 | Corticosteroid [EPC] | 88 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 59 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 54 |
| 4 | Interleukin-12 Antagonist [EPC] | 51 |
| 5 | Interleukin-23 Antagonist [EPC] | 51 |
| 6 | Proton Pump Inhibitor [EPC] | 34 |
| 7 | Integrin Receptor Antagonist [EPC] | 32 |
| 8 | Benzodiazepine [EPC] | 31 |
| 9 | Vitamin C [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Interleukin-12 Antagonist [EPC] | 51 | 0.0005 |
| 2 | Interleukin-23 Antagonist [EPC] | 51 | 0.0005 |
| 3 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 4 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |
| 5 | Nitroimidazole Antimicrobial [EPC] | 28 | 0.0004 |
| 6 | Bile Acid Sequestrant [EPC] | 5 | 0.0004 |
| 7 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 2 | 0.0004 |
| 8 | Integrin Receptor Antagonist [EPC] | 32 | 0.0004 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 14 | 0.0003 |